---
title: Sygnature Discovery vs Veloxity Labs
slug_a: sygnaturediscovery
slug_b: veloxitylabs
site: cro
review_signal_gate: closed
canonical_path: /compare/sygnaturediscovery/veloxitylabs
---

# Sygnature Discovery vs Veloxity Labs

Side-by-side profile data from each company listing on this directory.

## Sygnature Discovery

- Profile: [/companies/sygnaturediscovery](/companies/sygnaturediscovery)

Sygnature Discovery — Sygnature Discovery is an integrated drug discovery contract research organization offering target identification, hit-to-lead, lead optimization, computational design, protein science, and in vivo pharmacology services. The company partners with biotech and pharma clients across the US, Canada, the UK, and Europe.

Services: 9. Modalities: 5. Indications: 4. Locations: 2. Certifications: 0. The strongest documented coverage currently appears in services (9).

### Services

- Discovery Research
- Target Identification & Validation
- Medicinal Chemistry
- Computational & In-Silico Drug Discovery
- Protein Engineering
- In Vitro ADME / DMPK
- Preclinical In Vivo Studies
- In Vivo PK / PD Studies
- Bioinformatics & Data Science

### Modalities

- Small Molecule
- Biologics (Monoclonal Antibodies)
- Biologics (Other)
- Antibody-Drug Conjugate (ADC)
- Peptide

### Indications

- Oncology
- Immunology
- Neurology
- Metabolic

### Phases

- Discovery
- Preclinical (General)

### Sourcing models

- Data not yet provided.

## Veloxity Labs

- Profile: [/companies/veloxitylabs](/companies/veloxitylabs)

Veloxity Labs — Bioanalytical CRO delivering LC-MS/MS bioanalysis for small molecules, peptides, proteins, and ADCs, with method development and PK/TK support. The company reports 5-business-day study initiation and 98% on-time data delivery.

Services: 2. Modalities: 4. Indications: 0. Locations: 0. Certifications: 0. The strongest documented coverage currently appears in modalities (4).

### Services

- Bioanalysis
- LC-MS Bioanalysis (Small Molecule)

### Modalities

- Small Molecule
- Biologics (Other)
- Antibody-Drug Conjugate (ADC)
- Peptide

### Indications

- Data not yet provided.

### Phases

- Discovery
- Preclinical (General)

### Sourcing models

- Data not yet provided.